Ovarian Cancer Research Alliance (OCRA) is thrilled to announce a groundbreaking partnership with Microsoft’s AI for Health initiative. This unique collaboration will help OCRA accelerate ovarian cancer research by harnessing the power of data science and Artificial Intelligence (AI). With the support of Microsoft’s AI for Health initiative, a $60 million, five-year program, select OCRA grantees can utilize Microsoft’s … Continued
(August 6, 2020) Using medical records for 121 patients with gynecologic cancer and COVID-19, researchers were able to conduct an early look at the implications of a COVID-19 diagnosis on a patient with a gynecological cancer diagnosis. All of these patients were treated in the New York City area. Seventeen of the 121 patients (14.0%) … Continued
(July 27, 2020) Research from the Ovarian Cancer Association Consortium (OCAC) found that “using menopausal hormone therapy prior to diagnosis extends ovarian cancer survival.” This was found through a comprehensive analysis involving 6,419 post-menopausal women with ovarian carcinoma. Study authors concluded, “This large study is consistent with prior smaller studies, and further work is needed … Continued
Find resources and make connections at OCRA’s 2020 National Conference September 29 – October 2, 2020 Early Bird Registration Ends 7/31! We’ll be honest—when we decided to host our annual National Conference online this year, we were a little nervous. This meetup means so much to so many. It’s the place for ovarian cancer survivors, caregivers, supporters and experts … Continued
There’s so much happening at OCRA – from groundbreaking research to advocacy work, patient support to fundraising efforts. Starting this summer, we will share periodic highlights so that you can stay up to date on the latest. Research A pandemic won’t stop us from our mission to cure ovarian cancer. OCRA is now accepting applications for 2021 … Continued
(July 7, 2020) Presented as part of the American Association for Cancer Research (AACR) Virtual Annual Meeting, Dr. Kala Visvanathan and colleagues at Johns Hopkins found that statins “were associated with reduced mortality in patients with ovarian cancer.” Statins are commonly prescribed as a treatment for high cholesterol. Participants in this study who used statins … Continued
Hui Shen, PhD, spoke of a particular moment that helped cement her commitment to ovarian cancer research. She was working on a complicated project that required a new genomics technology to work. So she and her team enlisted help from an expert. “This technologist made it all happen,” Hui explained. “We were jumping up and down with the … Continued
(June 24, 2020) Published this month in the International Journal of Cancer, researchers in Australia have found that “A healthy lifestyle after diagnosis, in particular not smoking and being physically active, may help women with ovarian cancer improve their prognosis.” Over 500 women participated in the study, self-reporting smoking status, height, weight, physical activity, diet … Continued
Recently we announced that OCRA’s 2020 National Conference will take place virtually on September 29-October 2, 2020. We are very excited to bring you an amazing program featuring information on the latest ovarian cancer research and treatment, engaging breakout sessions, self-care and wellness support, and community-building activities, along with a few surprises too! We understand … Continued
Duygu Ozmadenci, PhD, grew up in a small town on the Black Sea region of Turkey, across the waters from Chernobyl. As a teenager, she read a book that told stories of generations of people living in Anatolia and the land that eventually became Turkey. The depictions of the geography and flora, the description of … Continued
(June 11, 2020) Letters of Intent (LOIs) for Ovarian Cancer Research Alliance’s 2021 scientific grant awards are now open for submission. LOIs are due by July 10, 2020. Accepting LOIs is step one of OCRA’s highly competitive grant process. After LOIs are received, they are reviewed by our Scientific Advisory Committee (SAC), an esteemed group … Continued
First-of-its-kind clinical trial validates remote genetic counseling (New York) June 01, 2020 – Genetic testing for cancer risk can significantly improve the prevention or treatment of hereditary cancers, but studies have shown that people who might have a genetic risk often don’t get tested. A collaborative Stand Up To Cancer ‘Dream Team’ of researchers co-funded … Continued
Get email updates about research news, action alerts, and ways to join the fight.
